Abstract 16516: Spironolactone In Patients With Atrial Fibrillation And Preserved Ejection Fraction Does Not Reduce Arrhythmia Burden: Results From A Randomized, Double-blind, Placebo-controlled Trial (INSPIRE-AF)

Dragana Rujic,Manan Pareek,Per Lav Madsen,Kenneth Egstrup,Tina Juhl Hansen

Abstract 16516: Spironolactone In Patients With Atrial Fibrillation And Preserved Ejection Fraction Does Not Reduce Arrhythmia Burden: Results From A Randomized, Double-blind, Placebo-controlled Trial (INSPIRE-AF)

2019

Dragana Rujic
Manan Pareek
Per Lav Madsen
Kenneth Egstrup
Tina Juhl Hansen

Background: Spironolactone has antifibrotic properties and may reduce the burden of arrhythmia in patients with atrial fibrillation (AF). Purpose: To evaluate the efficacy of spironolactone versus ...

Keywords:

double blind
in patient
Atrial fibrillation
Medicine
Internal medicine
Spironolactone
Placebo-controlled study
Aldosterone
Ejection fraction
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations